Scarica l'app Stockscreener
2.03
5.73%
0.11
Dopo l'orario di chiusura:
2.03
Precedente Chiudi:
$1.92
Aprire:
$1.95
Volume 24 ore:
20,708
Relative Volume:
0.33
Capitalizzazione di mercato:
$79.46M
Reddito:
$81,000
Utile/perdita netta:
$-31.93M
Rapporto P/E:
-3.0092
EPS:
-0.6746
Flusso di cassa netto:
$-26.35M
1 W Prestazione:
+0.00%
1M Prestazione:
-11.35%
6M Prestazione:
-33.66%
1 anno Prestazione:
-44.84%
Intervallo 1D:
$1.885
$2.06
Intervallo di 1 settimana:
$1.825
$2.0992
Portata 52W:
$1.37
$4.09
Sera Prognostics Inc Stock (SERA) Company Profile
Nome
Sera Prognostics Inc
Settore
Industria
Telefono
(801) 990-0520
Indirizzo
2749 E. PARLEYS WAY, SALT LAKE CITY
Compare SERA vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SERA
Sera Prognostics Inc
|
2.03 | 75.16M | 81,000 | -31.93M | -26.35M | -0.6746 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-15 | Iniziato | Jefferies | Buy |
| 2022-03-30 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | Oppenheimer | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
Sera Prognostics Inc Borsa (SERA) Ultime notizie
Sera Prognostics (SERA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Sera Prognostics (SERA) Raised to Buy: What Are the Implications for Its Shares? - Bitget
Fundamentals Check: How does Sera Prognostics Inc perform in inflationary periods2026 Retail Activity & Weekly High Return Forecasts - baoquankhu1.vn
Short Covering: What is Sera Prognostics Incs valuation compared to sectorWeekly Trade Report & Risk Managed Investment Entry Signals - baoquankhu1.vn
Sera Prognostics Q4 2025 Earnings Call Transcript - AOL.com
Market Pulse: Will Sera Prognostics Inc outperform tech stocksPortfolio Risk Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Robert Harrison sells SERA shares under 10b5-1 plan (SERA) - Stock Titan
Market Outlook: Whats the beta of Sera Prognostics Inc stockChart Signals & Safe Swing Trade Setups - baoquankhu1.vn
Sera Prognostics outlines plan to expand partner programs to 15–17 states by year-end 2026 while maintaining cash runway through 2028 - MSN
History Review: Is Sera Prognostics Inc stock a value trapPortfolio Return Report & Real-Time Stock Entry Alerts - baoquankhu1.vn
Sera Prognostics, Inc. (SERA) reports Q4 loss, lags revenue estimates - MSN
What is Dogwood Therapeutics Incs book value per shareMarket Trend Summary & Reliable Price Breakout Signals - baoquankhu1.vn
Bull Bear: Should I hold or sell Sera Prognostics Inc nowMarket Activity Recap & Weekly Breakout Watchlists - baoquankhu1.vn
Gains Report: Is Sera Prognostics Inc stock undervalued right nowNew Guidance & AI Based Buy and Sell Signals - baoquankhu1.vn
SERA SEC FilingsSera Prognostics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2025 Earnings Call Transcript - Insider Monkey
Sera Prognostics (NASDAQ: SERA) opens $40M ATM sales agreement with William Blair - Stock Titan
Sera Prognostics Earnings Call: Data-Rich, Revenue-Light - TipRanks
Sera Prognostics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Sera Prognostics Reports 2025 Financial Results: PRIME Study Validates PreTRM® Test, Expands U.S. and EU Commercialization, Secures $57.5M Financing 1 - Minichart
Sera Prognostics 2025 Annual Report: Innovative Biomarker Tests and Predictive Analytics for Pregnancy Care - Minichart
Sera Prognostics Inc (SERA) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada
Sera Prognostics Q4 Earnings Call Highlights - MarketBeat
Sera Prognostics 2025 Review: Commercialization and PreTRM ProgressNews and Statistics - IndexBox
Earnings call transcript: Sera Prognostics Q4 2025 results show EPS beat, revenue miss By Investing.com - Investing.com South Africa
Earnings call transcript: Sera Prognostics Q4 2025 results show EPS beat, revenue miss - Investing.com Canada
SERA: PRIME study results and payer engagement drive commercial momentum amid disciplined financials - TradingView
Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance Singapore
Sera Prognostics earnings beat by $0.03, revenue fell short of estimates - Investing.com Canada
Sera Prognostics Inc. (NASDAQ:SERA) Reports Q4 Revenue Miss, Narrower Loss - ChartMill
Stock Issuance Plan Details: Biotechnology company Sera Prognostics, Inc. (NASDAQ: SERA) announces the submission of a mixed shelf registration statement, planning to periodically issue Class A common stock in the future, with a total fundraising amount - Bitget
Sera Prognostics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Sera Prognostics (NASDAQ:SERA) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Sera Prognostics 2025 10-K: Revenue $0.08M, EPS $(0.67) - tradingview.com
SERA: PRIME Study validated PreTRM® Test, commercial expansion advanced, and cash runway secured - TradingView
Sera Prognostics (NASDAQ: SERA) outlines PreTRM strategy and pregnancy diagnostics pipeline - Stock Titan
Sera Prognostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Sera Prognostics (SERA) posts 2025 loss but holds $95.8M cash runway - Stock Titan
BRIEF-Sera Prognostics Q4 Revenue USD 10 Thousand - TradingView
SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS - PR Newswire
Geopolitics Watch: Is Sera Prognostics Inc in a long term uptrend2026 Reactions & Community Trade Idea Sharing Platform - baoquankhu1.vn
Sera Prognostics, Inc. (SERA) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
Sera Prognostics Fourth Quarter 2025 Earnings Conference Call Transcript - Bitget
Aug Summary: Is Sera Prognostics Inc stock heavily shorted2026 Movers & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Sera Prognostics Inc (SERA) Q4 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Sera Prognostics Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Fed Meeting: What is Sera Prognostics Incs revenue forecast2026 Historical Comparison & Fast Entry High Yield Tips - baoquankhu1.vn
Major employer is taking over Illinois hospital. Here are the details - AOL.com
Sera Prognostics (NASDAQ: SERA) grants CEO RSUs and stock options - Stock Titan
Sera Prognostics grants RSUs and options to counsel | SERA SEC FilingForm 4 - Stock Titan
SERA (SERA) Chief Medical Officer receives new stock options and RSUs - Stock Titan
Sera Prognostics Inc Azioni (SERA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sera Prognostics Inc Azioni (SERA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lindgardt Zhenya | Chief Executive Officer |
Mar 10 '26 |
Sale |
1.90 |
22,639 |
43,014 |
741,287 |
| Lindgardt Zhenya | Chief Executive Officer |
Mar 11 '26 |
Sale |
2.04 |
2,973 |
6,065 |
738,314 |
| Kearney Paul | Chief Data Officer |
Mar 11 '26 |
Sale |
2.04 |
1,396 |
2,848 |
163,961 |
| Jackson Benjamin | General Counsel |
Mar 11 '26 |
Sale |
2.04 |
1,027 |
2,095 |
114,720 |
| Harrison Robert Gardner | Chief Information Officer |
Mar 11 '26 |
Sale |
2.04 |
716 |
1,461 |
76,712 |
| Boniface John J. | Chief Scientific Officer |
Mar 11 '26 |
Sale |
2.04 |
1,517 |
3,095 |
145,842 |
| Aerts Austin | Chief Financial Officer |
Mar 10 '26 |
Sale |
1.90 |
6,069 |
11,531 |
265,471 |
| Aerts Austin | Chief Financial Officer |
Mar 11 '26 |
Sale |
2.04 |
1,019 |
2,079 |
264,452 |
2.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):